The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulent M.tb in a ‘challenge’ experiment following vacci...
主要な著者: | Tanner, R, Hoogkamer, E, Bitencourt, J, White, A, Boot, C, Sombroek, CC, Harris, SA, O'Shea, MK, Wright, D, Wittenberg, R, Sarfas, C, Satti, I, Verreck, FAW, Sharpe, SA, Fletcher, HA, McShane, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
F1000Research
2021
|
類似資料
-
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 1; peer review: 2 approved]
著者:: Rachel Tanner, 等
出版事項: (2021-03-01) -
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
著者:: Rachel Tanner, 等
出版事項: (2021-09-01) -
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
著者:: Tanner, R, 等
出版事項: (2021) -
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
著者:: Rachel Tanner, 等
出版事項: (2021-01-01) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
著者:: Pepponi, I, 等
出版事項: (2017)